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Abstract
Background A remote magnetic navigation (MN) system is
available for radiofrequency ablation of atrial fibrillation
(AF), challenging the conventional manual ablation technique.
The myocardial markers were measured to compare the
effects of the two types of MN catheters with those of a
manual-irrigated catheter in AF ablation.
Methods AF patients underwent an ablation procedure
using either a conventional manual-irrigated catheter
(CIR, n=65) or an MN system utilizing either an irrigated
(RMI, n=23) or non-irrigated catheter (RMN, n=26).
Levels of troponin T (TnT) and the cardiac isoform of
creatin kinase (CKMB) were measured before and after
ablation.
Results Mean procedure times and total ablation times were
longer employing the remote magnetic system. In all
groups, there were pronounced increases in markers of
myocardial injury after ablation, demonstrating a significant
correlation between total ablation time and post-ablation
levels of TnT and CKMB (CIR r=0.61 and 0.53, p<0.001;
RMI r=0.74 and 0.73, p<0.001; and RMN r=0.51 and 0.59,
p<0.01). Time-corrected release of TnT was significantly
higher in the CIR group than in the other groups. Of the
patients, 59.6% were free from AF at follow-up (12.2±
5.4 months) and there were no differences in success rate
between the three groups.
Conclusions Remote magnetic catheters may create more
discrete and predictable ablation lesions measured by
myocardial enzymes and may require longer total ablation
time to reach the procedural endpoints. Remote magnetic
non-irrigated catheters do not appear to be inferior to
magnetic irrigated catheters in terms of myocardial enzyme
release and clinical outcome.
Keywords Atrial fibrillation . Ablation .Myocardial
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1 Background
Radiofrequency ablation (RFA) has evolved as the treat-
ment of choice for drug-resistant atrial fibrillation (AF).
The electrical isolation of the pulmonary veins (PVs) is
regarded as one endpoint of ablation [1, 2], but more
extensive approaches, such as linear- or complex-
fractionated atrial electrogram (CFAE) ablation, may also
be employed. A remote magnetic navigation (MN) system
is available and has been shown to be feasible in treating
AF [1, 3]. A soft RFA catheter with a magnet can be guided
and positioned by directional magnetic fields. An irrigated
RFA catheter has been shown to be capable of enlarging the
size and improving the transmurality of ablation lesions
using manual catheters [4], but no equivalent data are
available for the MN system. A good tissue contact and
positional stability are believed to be some of the
advantages of the MN system, but it is not known whether
AF ablation using MN causes similar levels of myocardial
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injury as manual ablation. RFA induces local thermal
damage in the heart [5] and previous studies have shown
that traditional myocardial markers such as Troponin T (TnT)
and creatine kinase's cardiac isoenzyme MB (CKMB) are
sensitive measures of myocardial injury [6–11]. Most studies
have been performed when only limited ablation has been
applied.
In this study, we sought to determine the relative impacts
of the different catheters by measuring levels of myocardial
markers TnT and CKMB before and after AF ablation
using standard irrigated catheters and both irrigated and
non-irrigated MN catheters.
2 Methods
2.1 Patient selection
One hundred and fourteen highly symptomatic patients
with drug-resistant, paroxysmal or persistent AF referred
for RFA treatment were enrolled. Demographic and
clinical data were collected prior to the procedure
(Table 1). All patients were given oral anticoagulants for
at least 1 month before the procedure. Patients underwent
RFA either using a conventional manual-irrigated catheter
(CIR group, n=65) or a remote magnetic navigated
ablation procedure that employed irrigated (RMI group,
n=23) or non-irrigated (RMN group, n=26) catheters,
based on the operator's decision. We excluded patients
with renal failure, recent myocardial ischemia or clinical
signs of infection. All patients provided informed consent.
The study was performed in accordance with the Decla-
ration of Helsinki, and was approved by the local ethics
committee.
2.2 Ablation procedure
Patients underwent electrophysiological study and RFA
in a fasting, sedated state. Vascular access was obtained
under local anesthesia through the right and left femoral
veins. In all patients, a 7F 20-pole steerable mapping
catheter (Livewire, St. Jude Medical Inc, St. Paul, MN,
USA) was positioned in the coronary sinus looped
around the tricuspid annulus. After transseptal puncture,
a 10-pole circular mapping catheter (Lasso™, Biosense
Webster, Diamond Bar, CA, USA or Optima™, St. Jude
Medical Inc) was introduced into the left atrium (LA)
through an 8F transseptal introducer.
2.2.1 Conventional procedure
In the CIR group, an irrigated RFA catheter (ThermoCool®,
Biosense Webster or Navistar® ThermoCool, Biosense
Webster) was introduced into the LA through the same
puncture site without a second introducer. LA mapping
was performed using either Ensite NavX™ (St. Jude
Medical Inc.) or Carto™XP (Biosense Webster) systems.
All 65 patients in the CIR group underwent electrical
isolation of all PVs. The ablation consisted of continuous
circumferential lesions around each PV, with additional
ablation between the two PVs if needed. Twenty-two of
these patients underwent PV isolation only. The remainder
were given additional ablation of the cavotricuspid isthmus
line (n=9), two lines connecting the two contra-lateral
superior and inferior veins (n=7) [12], ablation on CFAEs
(n=8) or a combination (n=19). The application time of
RFA was 40–60 s at each site and energy was delivered
with a cut-off temperature of 50°C. The maximum
output and irrigation rates were 30–35 W, 15–20 mL/min
Table 1 Demographics and procedural data
CIR group (n=65) RMI group (n=23) RMN group (n=26)
Male (%) 51 (79%) 22 (96%)* 20 (77%)
Age (years) (± SD) 57±9 59±7 55±8
Paroxysmal AF (%) 40 (61%) 15 (65%) 14 (54%)
Lone AF (%) 35 (54%) 12 (52%) 13 (50%)
Prior AF ablation (%) 18 (28%) 7 (30%) 6 (23%)
PVI without additional ablation 22 (34%) 10 (43%) 6 (46%)a
Procedure time (min) (± SD) 215±61** 340±107 324±74a
Total ablation time (sec) (± SD) 3081±1515** 6565±2206*** 4737±1111a
Fluoroscopy time (min) (± SD) 46.1±17 53.7±22 54.5±21a
CIR group conventional manual irrigated catheter; RMI group remote magnetic navigation, irrigated catheter; RMN group remote magnetic
navigation, non-irrigated catheter; PVI pulmonary vein isolation; AF atrial fibrillation; SD standard deviation
aOnly those with PVI confirmed by a circular catheter were included (n=13)
*significant vs CIR and RMN, p<0.05; ** significant vs RMI and RMN, p<0.001; *** significant vs RMN, p<0.001
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(for PV isolation), 25 W, 15 mL/min in the coronary sinus
and 30–40 W, 20 mL/min for linear or CFAE ablation
(maximum 35 W in LA, 40 W in right atrium (RA)),
respectively [13].
2.2.2 Magnetically guided procedure
In the patients who underwent MN ablation, the RFA
catheter was introduced into the LA through a second
transseptal guiding introducer, and LA mapping was
performed by Carto™ RMT (Biosense Webster). The
three-dimensional mapping system was used in conjunction
with the Niobe® II system (Stereotaxis, St. Louis, MO, USA).
The ablation consisted of a continuous circumferential
line around the two ipsilateral PVs, with additional
ablation between the two PVs. Energy was applied only
when good electrode-tissue contact was indicated by the
system monitor. In the RMI group, a Navistar® RMT
ThermoCool® (Biosense Webster) ablation catheter was
employed. Thirteen patients underwent CFAE ablation
and three of these were given additional cavotricuspid
isthmus ablation. Application time, output and tempera-
ture cut-offs, and irrigation rate were the same as in the
CIR group. In the RMN group a Navistar Celsius RMT™
(Biosense Webster) ablation catheter was used. Eight
patients underwent additional CFAE ablation. In 13
patients of this group, the circular mapping catheter
was not employed and the PV isolation was confirmed
by RFA catheter only [14]. Energy was applied in
temperature-controlled mode, with a cut-off temperature
of 55°C and a maximum output of 40 W. Application time
was 20 s at each site [1, 14]. Charring of the catheter tip raises
its impedance and, if this was suspected, the catheter was
extracted and the tip checked out during the procedure.
In all three groups, a Stockert-Cordis (Biosense Webster)
RFA generator was utilized. Surface ECG and intracardiac
electrograms were recorded utilizing the multichannel
LabSystem™ Pro (Bard Electrophysiology, Lowell, MA,
USA). No direct-current cardioversion was performed
during the procedures.
2.3 Blood sampling and marker measurements
Venous blood samples for baseline data were drawn from
an antecubital vein before the procedure in all patients.
Post-procedure samples were collected the next morning,
24 h after the start of the procedure. TnT and CKMB
were determined using an electrochemiluminescence
immunoassay on a Modular E system (Roche Diagnostics,
Mannheim, Germany). The analytical detection limits were
0.01 μg/L (TnT) and 0.1 μg/L (CKMB), respectively. The
TnT cut-off value for diagnosis of myocardial infarction
according to ACC/AHA guidelines is 0.03 μg/L [15].
2.4 Follow-up
Follow-up was performed at the out-patient clinic or by
the patients' local hospitals and referring cardiologists. All
patients had clinical examination and at least one Holter
registration at 3 and 6 months after the procedure and further
ECG-recordings if indicated by symptoms. Recurrence
was defined as at least one episode of AF lasting more
than 60 s after a blanking period of 3 months. Patients
were followed for 1 year after the relevant ablation
procedure and clinical results were reported based on this
procedure only. Patients who underwent a repeat procedure
during the follow-up were therefore regarded as failure,
independent of the outcome of the last procedure.
3 Statistical analyses
For all statistical analyses, the SPSS software package version
17.0 (SPPS Inc., IL, USA) was used. Discrete variables
are reported as counts (percentages) and continuous
variables as mean±SD. Statistical comparisons were
performed using the χ2 for discrete variables and
Student's t test, Mann–Whitney U test or one-way
ANOVA for continuous variables. Correlations between
procedural variables and marker levels were calculated
using linear regression analysis and Spearman's rank
correlation tests. Levene's test was employed to test the
variances between groups. A p value of <0.05 was
considered to be statistically significant.
4 Results
4.1 Clinical and procedural data
The demographics and procedural data are shown in
Table 1. There were no differences in the distribution of
co-morbidity between the three groups. More male patients
were included in the RMI group compared to the RMN
and CIR groups (96% vs. 77% and 79%, p<0.01).
Thirty-one (27%) patients had undergone prior AF
ablation with an even distribution among the groups.
The Procedure time (skin-to-skin) and total ablation time
in the RMN group were 276±76 min and 3,619±1,464 s,
respectively. In the RMN group, procedure time (232±
46 min vs. 324±74 min, p<0.001) and total ablation time
(3,194±853 s vs. 4,737±1111 s, p<0.001) were signifi-
cantly shorter in patients for whom the circular mapping
catheter was not employed for confirmation of PV
isolation. Procedure and total ablation times were longer
in the RMI and RMN group than the CIR group (p<0.001,
Table 1). There were no statistically significant differences
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in fluoroscopy time between the three groups. No
procedure-related complications, such as cardiac tamponade,
atrioesophageal fistula, PV stenosis, transient ischemic attack
or major bleeding were observed in any of the patients.
4.2 Ablation impact and myocardial markers
Baseline myocardial marker levels were within the
normal range, and displayed a statistically significant
increase in both TnT and CKMB after ablation in all
groups (Table 2). After ablation there was a significantly
lower mean TnT level in the RMN group than in the other
groups (p<0.001). If the troponin level was corrected for
ablation time (TnTc), the mean TnTc (μg/L per 1000
seconds ablation) was considerably higher in the CIR
group than in either the RMN or RMI groups (0.61 vs.
0.30 and 0.23 μg/L, p<0.001). The difference in TnTc
between the RMN and RMI groups was also statistically
significant (p<0.05). Figure 1 shows a greater variance in
TnTc level in the CIR group than in either the RMN or
RMI groups (p<0.01). There were no differences in any
group in the release of TnTc between patients who
underwent PV isolation alone and those who underwent
additional LA or RA ablation (CIR group 0.63 and
0.61 μg/L, p=n.s.; RMI group 0.22 and 0.24 μg/L, p=n.s.;
RMN group 0.35 and 0.25 μg/L, p=0.062, respectively).
In all three groups there were lower levels of TnTc in
patients who had undergone prior AF ablation than in
those for the first-time procedure (CIR 0.49 vs. 0.67 μg/L,
p<0.001; RMI 0.16 vs. 0.26 μg/L, p<0.01; RMN 0.28 vs.
0.36 μg/L, p<0.01). There were no significant differences
between the proportions of patients undergoing repeat
procedures or ablation additional to PV isolation in the
three groups (Table 1). Within the RMN group, there was
a tendency towards higher levels of release of TnT in
patients when a circular mapping catheter was used (1.35
vs. 1.03 μg/L, p=0.09).
Further analysis revealed a significant correlation between
the total ablation time and post-ablation serum concentration
of TnT (CIR r=0.61, p<0.01; RMI r=0.74, p<0.001; and
RMN r=0.51, p<0.01, respectively; Fig. 2). Post-ablation
levels of CKMB also increased with total ablation time
in all groups (CIR r=0.53, p<0.001; RMI r=0.73, p<0.001;
and RMN: r=0.59, p=0.002; Fig. 2).
4.3 Clinical results
After a mean follow-up period of 12.2±5.4 months, 68
patients (59.6%) were free from AF recurrence, three
patients are still on anti arrhythmic drugs (two patients
in CIR group and one in RMI group). Twelve patients
used beta blockers because of hypertension or other
cardiovascular disease. Longstanding persistent AF
patients had significantly lower success rate than other
patients (35.0% vs. 66.0%, p<0.05). One patient died
during follow-up due to colorectal cancer. There were no
differences in success rate in the three different groups
(CIR 60.0%, RMI 61.0%, RMN 53.8%, p=n.s.). In the
RMN group, there was a significantly higher TnTc in
patients with successful ablation compared to patients with
recurrence of AF (0.43 vs. 0.25 μg/L, p<0.01), but there
were no such differences in the other groups (CIR 0.61 vs.
0.65 μg/L, p=n.s.; RMI 0.22 vs. 0.24 μg/L, p=n.s.). No
differences in total TnT was revealed between patients
with or without ablation success in any group.
5 Discussion
We measured the levels of myocardial markers TnT and
CKMB in patients who underwent manual or remote MN
RFA for AF. Previous studies on Troponin I or T have
produced diverging results regarding the relationship
between enzyme release and the number of RFA lesions
and site of RFA [6–10]. Our study demonstrates a
significant positive correlation between myocardial marker
levels and total ablation time with both manual and MN
catheters.
A considerably lower time-corrected TnT level (TnTc)
was associated with the MN system, whether irrigated or
non-irrigated catheters were employed. This suggests that
myocardial injury, as indicated by enzyme release, was
Table 2 Level of myocardial markers at baseline and after ablation
Myocardial marker CIR group RMI group RMN group
Baseline After RFA Baseline After RFA Baseline After RFA
TnT (±SD) μg/L <0.03 1.68±0.9* <0.03 1.63±0.9* <0.03 1.18±0.5*,**
CKMB (±SD) μg/L 3.4±1.9 10.1±4.0* 4.1±2.3 10.5±6.3* 3.4±1.5 10.2±3.5*
CIR group conventional manual irrigated catheter; RMI group remote magnetic navigation, irrigated catheter; RMN group remote magnetic
navigation, non-irrigated catheter; RFA radiofrequency ablation; TnT troponin T; CKBM creatine kinase's myocardial isoform; SD standard
deviation
*p<0.001, compared to baseline; **significant vs. RMI and CIR, p<0.001
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lower with the MN system than with the manual ablation
technique. Lesions created by MN may appear to be more
sharply defined because of the positional stability of the
system in comparison with manual catheters, and may
therefore cause less myocardial damage and still be
effective. It has been suggested that similar mechanisms
are involved in cryoablation, when the ablation catheter
freezes to the endocardium [16–19].
The manual catheters might be less stable and slide over
the endocardium resulting in larger, but shallower and thus
less effective, ablation lesions. This lack of stability also
might create more inexpedient myocardial damage. AF
patients are reported to have a thinner posterior atrial wall
[20] and a stable catheter position during ablation may
produce transmurality more rapidly than the preset ablation
time.
Our results revealed an unexpectedly higher time-
corrected release of TnT using a non-irrigated MN
catheter than an irrigated catheter. One possible explana-
tion is that the irrigation flow (15–20 ml/min) might
reduce the electrode-tissue contact for the soft catheter.
In these two groups there were also different application
time, temperature and output cut-off settings, with the
highest output and shortest application time in the RMN
Fig. 1 Scattergrams of ablation time-corrected serum troponin T
level. Mean values with error bars of one standard deviation are
shown. Note: there was a larger variance in time-corrected troponin T
in the CIR group than in either the RMI or the RMN groups (p<0.01).
CIR conventional manual irrigated catheter, RMI remote magnetic
irrigated catheter, RMN remote magnetic non-irrigated catheter
Fig. 2 Correlation of troponin T (TnT) and cardiac creatin kinase
(CKMB) with total ablation time. Upper panels, relationship between
serum troponin T level and total ablation time. Lower panels,
relationship between serum CKMB level and total ablation time.
Plots show significant correlations between the myocardial marker
levels and total ablation time in all groups. Y-axis serum levels of
troponin T (micrograms per liter) or CKMB (micrograms per liter).
X-axis total ablation time (seconds). CIR, RMI, RMN; see Fig. 1
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group. The short application time was employed to
reduce the risk of char formation [21]. Efficiency is
lower during the first few seconds of RFA delivery, until
the output reaches a plateau and the lesions might be
enlarged up to 180 s of energy delivery [22, 23]. A longer
time to the plateau phase and longer ablation time at each
site in the RMI group may have led to a lower TnTc.
On the other hand, the irrigation rate and energy settings
were identical in the CIR and RMI groups, and the longer
total ablation times in the RMI group did not result in
higher levels of myocardial marker release. With the MN
system, catheter-tissue contact status can be monitored but
no guidance of catheter-tissue contact is yet available with
manual catheter ablation. A substantially stronger contact
force might create deeper ablation lesions [24, 25]. Our
analysis revealed a stronger correlation between TnT and
ablation time with the remote irrigated than the manual
irrigated catheter. A possible explanation is that the stable
positioning and the low and stable pressure obtained with a
remote catheter create more discrete ablation lesions and by
that a more predictable ablation effect (Fig. 1). New
methods of measuring contact force are being developed,
and further studies need to be performed on this subject.
There were no differences in TnTc levels using the MN
system between patients who underwent PV isolation alone
or who were given additional ablation in the atria. This
suggests that catheter movement and tissue contact using
remote MN are similar at the PV ostia and the other atrial
locations. A lower level of myocardial marker release was
observed in patients who underwent a repeat procedure.
Ablation on scars or partly fibrous tissue is not expected to
produce a similar release of myocardial markers as ablation
on healthy tissue, thus energy was not delivered to areas
without electrical signals. Longer procedure and ablation
times were needed if a circular mapping catheter was
employed to confirm PV isolation (RMN group), supported
by the tendency towards higher myocardial marker release
in these patients. Since better clinical outcomes have been
demonstrated with proven PV isolation [26, 27], it may be
necessary to employ a circular mapping catheter also during
magnetic navigated AF ablation procedures.
This study was non-randomized, but there were similar
baseline characteristics and portions of patients with prior
AF ablation or ablation extensive to PV isolation in the
three groups. There were no statistically significant
differences in outcome using the different ablation
catheters, although there was a tendency to higher AF
recurrence rate in the RMN group. Neither were there any
differences in marker levels in patients with or without
ablation success. In all groups, the proportion of complete
PVI and additional tailored ablation on CFAE or complete
cavotricuspid isthmus block was similar. This indicates
that the choice of procedural strategy is more important
than the type of catheter used to reach the endpoints of
ablation.
5.1 Study limitations
This study was non-randomized which may limit the
significance of the outcome on comparisons of the different
catheters. The study groups were not identical in size and
the numbers of patients in both groups on which the MN
system was utilized were relatively small. Although similar
proportions of patients underwent individually tailored
ablation additional to PV isolation, this approach may limit
the interpretation of the clinical results. The temperatures
reached and the energy delivered to produce individual
lesions was not recorded for comparison. Quantification of
electrode-tissue contact and force were not yet an option.
The operators' limited experience with the MN system may
have had an impact on procedure time, but all operators
were experienced electrophysiologists.
6 Conclusions
Remote magnetic catheters may create more discrete ablation
lesions with a more predictable effect as measured by
myocardial enzymes. Employing this system may require
longer ablation time to reach the procedural endpoints than
manual procedures. Remote magnetic non-irrigated catheters
do not appear to be inferior to magnetic irrigated catheters in
terms of myocardial marker release and clinical outcome.
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